Literature DB >> 19826106

Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample.

Marius R Robciuc1, Esa Tahvanainen, Matti Jauhiainen, Christian Ehnholm.   

Abstract

We have developed and validated quantitative ELISAs for human angiopoietin-like (ANGPTL)3 and 4 and correlated their serum levels with parameters of lipid and carbohydrate metabolism. For this study, we used a random subsample of the Health 2000 Health Examination Survey consisting of 125 men and 125 women, aged 30-94 years. The anthropometric and biochemical parameters of subjects were characterized in detail. ANGPTL 3 and 4 levels were determined using the developed ELISAs. The intra- and inter-assay coefficients of variation for the assays were less than 15%. The average serum concentration of ANGPTL3 was 368 +/- 168 ng/ml (mean +/- SD) and for ANGPTL4 it was 18 +/- 23 ng/ml (mean +/- SD). ANGPTL4 serum levels displayed high variability between individuals ranging from 2 to 158 ng/ml. In post-heparin plasma, both ANGPTL 3 and 4 were increased. Low levels of ANGPTL3 were associated with decreased HDL-cholesterol and increased triglyceride levels. ANGPTL4 levels were positively correlated with FFAs (P = 0.044) and waist-hip ratio (P = 0.016). The developed ELISAs will be important tools to clarify the role of ANGPTL 3 and 4 in human energy metabolism and partitioning of triglycerides between sites of storage (adipose tissue) and oxidation (skeletal and cardiac muscle).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19826106      PMCID: PMC2842146          DOI: 10.1194/jlr.M002618

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  33 in total

1.  Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase.

Authors:  Mitsuru Shimamura; Morihiro Matsuda; Hiroaki Yasumo; Mitsuyo Okazaki; Kazunori Fujimoto; Keita Kono; Tetsuya Shimizugawa; Yosuke Ando; Ryuta Koishi; Takafumi Kohama; Naohiko Sakai; Kazuaki Kotani; Ryutaro Komuro; Tatsuo Ishida; Kenichi Hirata; Shizuya Yamashita; Hidehiko Furukawa; Iichiro Shimomura
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-16       Impact factor: 8.311

2.  The Role of Heparin in Lipoprotein Metabolism.

Authors:  C B Anfinsen; E Boyle; R K Brown
Journal:  Science       Date:  1952-05-30       Impact factor: 47.728

3.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

Review 4.  Lipoprotein lipase: genetics, lipid uptake, and regulation.

Authors:  Martin Merkel; Robert H Eckel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2002-12       Impact factor: 5.922

5.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

Authors:  Stefano Romeo; Len A Pennacchio; Yunxin Fu; Eric Boerwinkle; Anne Tybjaerg-Hansen; Helen H Hobbs; Jonathan C Cohen
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

6.  Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.

Authors:  S Kersten; S Mandard; N S Tan; P Escher; D Metzger; P Chambon; F J Gonzalez; B Desvergne; W Wahli
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

7.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

Authors:  Stefano Romeo; Wu Yin; Julia Kozlitina; Len A Pennacchio; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.

Authors:  Tetsuya Shimizugawa; Mitsuru Ono; Mitsuru Shimamura; Kenichi Yoshida; Yosuke Ando; Ryuta Koishi; Kenjiro Ueda; Toshimori Inaba; Hiroyuki Minekura; Takafumi Kohama; Hidehiko Furukawa
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

10.  ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.

Authors:  Philippa J Talmud; Melissa Smart; Edward Presswood; Jackie A Cooper; Viviane Nicaud; Fotios Drenos; Jutta Palmen; Michael G Marmot; S Matthijs Boekholdt; Nicholas J Wareham; Kay-Tee Khaw; Meena Kumari; Steve E Humphries
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-30       Impact factor: 8.311

View more
  49 in total

1.  Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.

Authors:  Terje Robal; Mikael Larsson; Miina Martin; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia.

Authors:  Kasey C Vickers; Bassem M Shoucri; Michael G Levin; Han Wu; Daniel S Pearson; David Osei-Hwedieh; Francis S Collins; Alan T Remaley; Praveen Sethupathy
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

3.  Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.

Authors:  Sergio Fazio; Jessica Minnier; Michael D Shapiro; Sotirios Tsimikas; Patrizia Tarugi; Maurizio R Averna; Marcello Arca; Hagai Tavori
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

Review 4.  ANGPTL4 in Metabolic and Cardiovascular Disease.

Authors:  Binod Aryal; Nathan L Price; Yajaira Suarez; Carlos Fernández-Hernando
Journal:  Trends Mol Med       Date:  2019-06-21       Impact factor: 11.951

Review 5.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

6.  Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.

Authors:  Yu-Xin Xu; Valeska Redon; Haojie Yu; William Querbes; James Pirruccello; Abigail Liebow; Amy Deik; Kevin Trindade; Xiao Wang; Kiran Musunuru; Clary B Clish; Chad Cowan; Kevin Fizgerald; Daniel Rader; Sekar Kathiresan
Journal:  Atherosclerosis       Date:  2017-09-21       Impact factor: 5.162

7.  Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.

Authors:  Ranganath Muniyappa; Brent S Abel; Asha Asthana; Mary F Walter; Elaine K Cochran; Alan T Remaley; Monica C Skarulis; Phillip Gorden; Rebecca J Brown
Journal:  J Clin Lipidol       Date:  2017-02-24       Impact factor: 4.766

8.  Atypical angiopoietin-like protein that regulates ANGPTL3.

Authors:  Fabiana Quagliarini; Yan Wang; Julia Kozlitina; Nick V Grishin; Rhonda Hyde; Eric Boerwinkle; David M Valenzuela; Andrew J Murphy; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

9.  Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.

Authors:  Brandon S J Davies; Chris N Goulbourne; Richard H Barnes; Kirsten A Turlo; Peter Gin; Sue Vaughan; David J Vaux; André Bensadoun; Anne P Beigneux; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2012-09-24       Impact factor: 5.922

10.  Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation.

Authors:  Michael J Lafferty; Kira C Bradford; Dorothy A Erie; Saskia B Neher
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.